A role for altered phagosome maturation in the long-term persistence of Helicobacter pylori infection

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 303, Issue 2, 2012, Pages

  Borlace, Glenn N ^a   Keep, Stacey J ^a   Prodoehl, Mark J R ^a   Jones, Hilary F ^a   Butler, Ross N ^a   Brooks, Doug A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Chronic inflammation; Gastric cancer; Macrophage; Phagocyt ic killing; Ulce

Indexed keywords

AMOXICILLIN; ANTIBODY; BISMUTH; CLARITHROMYCIN; CYTOKINE; HELICOBACTER PYLORI VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTOFERRIN; METRONIDAZOLE; PROBIOTIC AGENT; PROTEIN KINASE C; PROTON PUMP INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TETRACYCLINE; VIRULENCE FACTOR;

ACIDIFICATION; ADAPTIVE IMMUNITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY RESPONSE; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; CELL PH; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; PEPTIC ULCER; PHAGOCYTES; PHAGOCYTOSIS; PHAGOSOMES;

EID: 84863897704     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00320.2011     Document Type: Article

References (156)

1. Aebischer T, Bumann D, Epple HJ, Metzger W, Schneider T, Cherepnev G, Walduck AK, Kunkel D, Moos V, Loddenkemper C, Jiadze I, Panasyuk M, Stolte M, Graham DY, Zeitz M, Meyer TF. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57: 1065-1072, 2008.
2. Akhiani AA, Pappo J, Kabok Z, Schon K, Gao W, Franzen LE, Lycke N. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 169: 6977-6984, 2002.
3. Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol 172: 5024-5033, 2004.
4. Algood HM, Allen SS, Washington MK, Peek RM Jr, Miller GG, Cover TL. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol 183: 5837-5846, 2009.
5. Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19: 597-613, 2006.
6. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Imunol Med Microbiol 51: 577-586, 2007.
7. Allen LA. Intracellular niches for extracellular bacteria: lessons from Helicobacter pylori. J Leukoc Biol 66: 753-756, 1999.
8. Allen LA. Modulating phagocyte activation: the pros and cons of Helicobacter pylori virulence factors. J Exp Med 191: 1451-1454, 2000.
9. Allen LA. Phagocytosis and persistence of Helicobacter pylori. Cell Microbiol 9: 817-828, 2007.
10. Allen LA. The role of the neutrophil and phagocytosis in infection caused by Helicobacter pylori. Curr Opin Infect Dis 14: 273-277, 2001.
11. Allen LA, Allgood JA. Atypical protein kinase Cζ is essential for delayed phagocytosis of Helicobacter pylori. Curr Biol 12: 1762-1766, 2002.
12. Allen LA, Allgood JA, Han X, Wittine LM. Phosphoinositide 3-kinase regulates actin polymerization during delayed phagocytosis of Helicobacter pylori. J Leukoc Biol 78: 220-230, 2005.
13. Allen LA, Beecher BR, Lynch JT, Rohner OV, Wittine LM. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 174: 3658-3667, 2005.
14. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 191: 115-128, 2000.
15. Amieva MR, Salama NR, Tompkins LS, Falkow S. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol 4: 677-690, 2002.
16. Andersen LP, Blom J, Nielsen H. Survival and ultrastructural changes of Helicobacter pylori after phagocytosis by human polymorphonuclear leukocytes and monocytes. APMIS 101: 61-72, 1993.
17. Andersen LP, Holck S. Possible evidence of invasiveness of Helicobacter (Campylobacter) pylori. Eur J Clin Microbiol Infect Dis 9: 135-138, 1990.
18. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastroduodenal diseases. Annu Rev Pathol 1: 63-96, 2006.
19. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 18: 479-486, 2010.
20. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114: 482-492, 1998.
21. Basu M, Czinn SJ, Blanchard TG. Absence of catalase reduces longterm survival of Helicobacter pylori in macrophage phagosomes. Helicobacter 9: 211-216, 2004.
22. Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 117: 316-323, 1999.
23. Beron W, Gutierrez MG, Rabinovitch M, Colombo MI. Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect Immun 70: 5816-5821, 2002.
24. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235-238, 2006.
25. Birkness KA, Gold BD, White EH, Bartlett JH, Quinn FD. In vitro models to study attachment and invasion of Helicobacter pylori. Ann NY Acad Sci 797: 293-295, 1996.
26. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161: 626-633, 1990.
27. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 94: 4-8, 1994.
28. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 54: 139-150, 1998.
29. Borlace GN, Butler RN, Brooks DA. Monocyte and macrophage killing of Helicobacter pylori: relationship to bacterial virulence factors. Helicobacter 13: 380-387, 2008.
30. Borlace GN, Jones HF, Keep SJ, Butler RN, Brooks DA. Helicobacter pylori phagosome maturation in primary human macrophages. Gut Pathog 3: 3, 2011.
31. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 13: 1-6, 2008.
32. Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K, Cao H, Popescu C, Gurney M, Hotha S, Cherian J, Rhee K, Ly L, Converse PJ, Ehrt S, Vandal O, Jiang X, Schneider J, Lin G, Nathan C. Selective killing of nonreplicating mycobacteria. Cell Host Microbe 3: 137-145, 2008.
33. Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211-215, 2000.
34. Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter 10: 40-46, 2005.
35. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol 12: 199-203, 2006.
36. Chmiela M, Paziak-Domanska B, Wadstrom T. Attachment, ingestion and intracellular killing of Helicobacter pylori by human peripheral blood mononuclear leukocytes and mouse peritoneal inflammatory macrophages. FEMS Immunol Med Microbiol 10: 307-316, 1995.
37. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 2: 58-60, 1975.
38. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 133: 659-672, 2007.
39. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284: 1328-1333, 1999.
40. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 215: 3-10, 1996.
41. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338: 332-335, 1991.
42. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158: 962-967, 1997.
43. de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Cristiani F, Santi S, Rossi M, Marchi S. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 102: 951-956, 2007.
44. De Wever O, Derycke L, Hendrix A, De Meerleer G, Godeau F, Depypere H, Bracke M. Soluble cadherins as cancer biomarkers. Clin Exp Metastasis 24: 685-697, 2007.
45. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136: 247-256, 2009.
46. Desjardins M, Celis JE, van Meer G, Dieplinger H, Jahraus A, Griffiths G, Huber LA. Molecular characterization of phagosomes. J Biol Chem 269: 32194-32200, 1994.
47. Desjardins M, Huber LA, Parton RG, Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol 124: 677-688, 1994.
48. Dubois A, Boren T. Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol 9: 1108-1116, 2007.
49. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 10: 720-741, 1997.
50. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
51. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113: 15-24, 1997.
52. El-Zimaity HM, Graham DY. Ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori. Ultrastruct Pathol 25: 159, 2001.
53. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188: 2277-2288, 1998.
54. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54: 615-640, 2000.
55. Evans DJ Jr, Evans DG, Takemura T, Nakano H, Lampert HC, Graham DY, Granger DN, Kvietys PR. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 63: 2213-2220, 1995.
56. Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 7: 355-366, 2009.
57. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 220: 23-26, 1996.
58. Gauthier NC, Monzo P, Gonzalez T, Doye A, Oldani A, Gounon P, Ricci V, Cormont M, Boquet P. Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J Cell Biol 177: 343-354, 2007.
59. Gauthier NC, Monzo P, Kaddai V, Doye A, Ricci V, Boquet P. Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol Biol Cell 16: 4852-4866, 2005.
60. Gobert AP, Bambou JC, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL. Helicobacter pylori heat shock protein 60 mediates interleukin- 6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 279: 245-250, 2004.
61. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 98: 13844-13849, 2001.
62. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59: 1143-1153, 2010.
63. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53: 1235-1243, 2004.
64. Guiney DG, Hasegawa P, Cole SP. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 71: 4163-4166, 2003.
65. Hafsi N, Voland P, Schwendy S, Rad R, Reindl W, Gerhard M, Prinz C. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173: 1249-1257, 2004.
66. Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, Smith PD. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis 178: 1516-1520, 1998.
67. Hoy B, Lower M, Weydig C, Carra G, Tegtmeyer N, Geppert T, Schroder P, Sewald N, Backert S, Schneider G, Wessler S. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep 11: 798-804, 2010.
68. Huynh KK, Grinstein S. Regulation of vacuolar pH and its modulation by some microbial species. Microbiol Mol Biol Rev 71: 452-462, 2007.
69. Ito T, Kobayashi D, Uchida K, Takemura T, Nagaoka S, Kobayashi I, Yokoyama T, Ishige I, Ishige Y, Ishida N, Furukawa A, Muraoka H, Ikeda S, Sekine M, Ando N, Suzuki Y, Yamada T, Suzuki T, Eishi Y. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest 88: 664-681, 2008.
70. Jordao L, Bleck CK, Mayorga L, Griffiths G, Anes E. On the killing of mycobacteria by macrophages. Cell Microbiol 10: 529-548, 2008.
71. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1α/β, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-α. J Gastroenterol Hepatol 12: 473-480, 1997.
72. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 12: 89-102, 2007.
73. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138: 1046-1054, 2010.
74. Karttunen R, Karttunen T, Ekre HP, MacDonald TT. Interferon-γ and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36: 341-345, 1995.
75. Keep S, Borlace G, Butler R, Brooks D. Role of immune serum in the killing of Helicobacter pylori by macrophages. Helicobacter 15: 177-183, 2010.
76. Khamri W, Moran AP, Worku ML, Karim QN, Walker MM, Annuk H, Ferris JA, Appelmelk BJ, Eggleton P, Reid KB, Thursz MR. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun 73: 7677-7686, 2005.
77. + T lymphocytes. Infect Immun 78: 845-853, 2010.
78. Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 110: 452-458, 1996.
79. Kido M, Tanaka J, Aoki N, Iwamoto S, Nishiura H, Chiba T, Watanabe N. Helicobacter pylori promotes the production of thymic stromal lymphopoietin by gastric epithelial cells and induces dendritic cell-mediated inflammatory Th2 responses. Infect Immun 78: 108-114, 2010.
80. Kindt TJ, Goldsby RA, Osborne BA. Kuby Immunology. New York: Freeman, 2007.
81. Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS, Shnier R, Portek IJ. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 54: 1122-1131, 2006.
82. Kishimoto T. IL-6: from laboratory to bedside. Clin Rev Allergy Immunol 28: 177-186, 2005.
83. Kranzer K, Eckhardt A, Aigner M, Knoll G, Deml L, Speth C, Lehn N, Rehli M, Schneider-Brachert W. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect Immun 72: 4416-4423, 2004.
84. Kranzer K, Sollner L, Aigner M, Lehn N, Deml L, Rehli M, Schneider-Brachert W. Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun 73: 4180-4189, 2005.
85. Kwok T, Backert S, Schwarz H, Berger J, Meyer TF. Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipperlike mechanism. Infect Immun 70: 2108-2120, 2002.
86. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162: 2347-2352, 1999.
87. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 12 Suppl 1: 1-3, 2007.
88. Li Y, Wandinger-Ness A, Goldenring JR, Cover TL. Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin. Mol Biol Cell 15: 1946-1959, 2004.
89. Loughlin MF, Arandhara V, Okolie C, Aldsworth TG, Jenks PJ. Helicobacter pylori mutants defective in the clpP ATP-dependent protease and the chaperone clpA display reduced macrophage and murine survival. Microb Pathog 46: 53-57, 2009.
90. Loughlin MF, Barnard FM, Jenkins D, Sharples GJ, Jenks PJ. Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect Immun 71: 2022-2031, 2003.
91. Lower M, Geppert T, Schneider P, Hoy B, Wessler S, Schneider G. Inhibitors of Helicobacter pylori protease HtrA found by "virtual ligand" screening combat bacterial invasion of epithelia. PLos One 6: e17986, 2011.
92. + CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73: 523-531, 2005.
93. Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 105: 65-73, 2010.
94. Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 165: 5332-5337, 2000.
95. Mattsson A, Quiding-Jarbrink M, Lonroth H, Hamlet A, Ahlstedt I, Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 66: 2705-2712, 1998.
96. Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection. Infect Immun 60: 5013-5016, 1992.
97. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 68: 6265-6272, 2000.
98. Mitchison DA. A new antituberculosis drug that selectively kills nonmultiplying Mycobacterium tuberculosis. Cell Host Microbe 3: 122-124, 2008.
99. Mobley HL, Hu LT, Foxal PA. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol 187: 39-46, 1991.
100. Morozov IA. Possibility of Helicobacter pylori invasion into the lamina propria of the gastric mucosa. Arkh Patol 56: 19-22, 1994.
101. Moujaber T, Macintyre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 12: 500-504, 2008.
102. Muller A, Solnick JV. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 16 Suppl 1: 26-32, 2011.
103. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182, 2006.
104. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219: 88-102, 2007.
105. Necchi V, Candusso ME, Tava F, Luinetti O, Ventura U, Fiocca R, Ricci V, Solcia E. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology 132: 1009-1023, 2007.
106. Nishi T, Okazaki K, Kawasaki K, Fukui T, Tamaki H, Matsuura M, Asada M, Watanabe T, Uchida K, Watanabe N, Nakase H, Ohana M, Hiai H, Chiba T. Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pyloriinfected neonatally thymectomized BALB/c mice. Infect Immun 71: 2153-2162, 2003.
107. O'Keeffe J, Moran AP. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 13: 1-19, 2008.
108. O'Rourke J, Bode G. Morphology and ultrastructure. In: Helicobacter pylori: Physiology and Genetics, edited by Mobley HL, Mendz G, Hazell SL. Washington, DC: Am. Soc. Microbiol., 2001.
109. Odenbreit S. Adherence properties of Helicobacter pylori: impact on pathogenesis and adaptation to the host. Int J Med Microbiol 295: 317-324, 2005.
110. Odenbreit S, Gebert B, Puls J, Fischer W, Haas R. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell Microbiol 3: 21-31, 2001.
111. Odenbreit S, Linder S, Gebert-Vogl B, Rieder G, Moran AP, Haas R. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 11: 196-207, 2006.
112. Olczak AA, Wang G, Maier RJ. Up-expression of NapA and other oxidative stress proteins is a compensatory response to loss of major Helicobacter pylori stress resistance factors. Free Radic Res 39: 1173-1182, 2005.
113. Otani K, Watanabe T, Tanigawa T, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun 382: 252-258, 2009.
114. Ozbek A, Ozbek E, Dursun H, Kalkan Y, Demirci T. Can Helicobacter pylori invade human gastric mucosa? An in vivo study using electron microscopy, immunohistochemical methods, and real-time polymerase chain reaction. J Clin Gastroenterol 44: 416-422, 2010.
115. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044, 2006.
116. Pellicano A, Sebkova L, Monteleone G, Guarnieri G, Imeneo M, Pallone F, Luzza F. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect Immun 75: 1738-1744, 2007.
117. Pesci EC, Pickett CL. Genetic organization and enzymatic activity of a superoxide dismutase from the microaerophilic human pathogen, Helicobacter pylori. Gene 143: 111-116, 1994.
118. Petersen AM, Blom J, Andersen LP, Krogfelt KA. Role of strain type, AGS cells and fetal calf serum in Helicobacter pylori adhesion and invasion assays. FEMS Immunol Med Microbiol 29: 59-67, 2000.
119. Petersen AM, Krogfelt KA. Helicobacter pylori: an invading microorganism? FEMS Immunol Med Microbiol 36: 117-126, 2003.
120. Petersen AM, Sorensen K, Blom J, Krogfelt KA. Reduced intracellular survival of Helicobacter pylori vacA mutants in comparison with their wild-types indicates the role of VacA in pathogenesis. FEMS Immunol Med Microbiol 30: 103-108, 2001.
121. Quiding-Jarbrink M, Raghavan S, Sundquist M. Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLos One 5: e15018, 2010.
122. Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27: 642-647, 1986.
123. Rautelin H, Blomberg B, Fredlund H, Jarnerot G, Danielsson D. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 34: 599-603, 1993.
124. Rautelin H, von Bonsdorff CH, Blomberg B, Danielsson D. Ultrastructural study of two patterns in the interaction of Helicobacter pylori with neutrophils. J Clin Pathol 47: 667-669, 1994.
125. Rautemaa R, Rautelin H, Puolakkainen P, Kokkola A, Karkkainen P, Meri S. Survival of Helicobacter pylori from complement lysis by binding of GPI-anchored protectin (CD59). Gastroenterology 120: 470-479, 2001.
126. Rittig MG, Shaw B, Letley DP, Thomas RJ, Argent RH, Atherton JC. Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell Microbiol 5: 887-899, 2003.
127. Rokita E, Makristathis A, Presterl E, Rotter ML, Hirschl AM. Helicobacter pylori urease significantly reduces opsonization by human complement. J Infect Dis 178: 1521-1525, 1998.
128. Romano PS, Gutierrez MG, Beron W, Rabinovitch M, Colombo MI. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cell Microbiol 9: 891-909, 2007.
129. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C, Rossi F. The neutrophilactivating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191: 1467-1476, 2000.
130. Schwartz JT, Allen LA. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J Leukoc Biol 79: 1214-1225, 2006.
131. Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, Wu C, Mao XH, Jia KR, Wang FJ, Guo H, Flavell RA, Zhao Z, Liu KY, Xiao B, Guo Y, Zhang WJ, Zhou WY, Guo G, Zou QM. Helicobacter pyloriinduced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184: 5121-5129, 2010.
132. Shin S, Roy CR. Host cell processes that influence the intracellular survival of Legionella pneumophila. Cell Microbiol 10: 1209-1220, 2008.
133. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J Immunol 165: 1022-1029, 2000.
134. Steer HW. Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. J Clin Pathol 28: 639-646, 1975.
135. Su B, Johansson S, Fallman M, Patarroyo M, Granstrom M, Normark S. Signal transduction-mediated adherence and entry of Helicobacter pylori into cultured cells. Gastroenterology 117: 595-604, 1999.
136. Sundquist M, Quiding-Jarbrink M. Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies. Expert Rev Gastroenterol Hepatol 4: 733-744, 2010.
137. Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol 78: 28-30, 2000.
138. Suzuki T, Kato K, Ohara S, Noguchi K, Sekine H, Nagura H, Shimosegawa T. Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathol Int 52: 265-271, 2002.
139. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 18: 5517-5527, 1999.
140. Terebiznik MR, Vazquez CL, Torbicki K, Banks D, Wang T, Hong W, Blanke SR, Colombo MI, Jones NL. Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect Immun 74: 6599-6614, 2006.
141. Tosi MF, Czinn SJ. Opsonic activity of specific human IgG against Helicobacter pylori. J Infect Dis 162: 156-162, 1990.
142. Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 31: 546-550, 1996.
143. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136: 2237-2246 e2231, 2009.
144. Vergne I, Chua J, Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: selective targeting of PI3P-dependent membrane trafficking. Traffic 4: 600-606, 2003.
145. Versalovic J, Fox JG. Helicobacter. In: Manual of Clinical Microbiology, edited by Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH. Washington, DC: Am. Soc. Microbiol., 2003, p. 915-928.
146. Voland P, Hafsi N, Zeitner M, Laforsch S, Wagner H, Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect Immun 71: 3837-3843, 2003.
147. Wang G, Alamuri P, Maier RJ. The diverse antioxidant systems of Helicobacter pylori. Mol Microbiol 61: 847-860, 2006.
148. +-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 287: 482-485, 2000.
149. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291: 187-194, 2004.
150. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23: 713-739, 2010.
151. Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 39: 863-870, 1986.
152. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41: 442-451, 1997.
153. Zheng PY, Jones NL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol 5: 25-40, 2003.
154. Zhou YN, Coleman WG Jr, Yang Z, Yang Y, Hodgson N, Chen F, Jin DJ. Regulation of cell growth during serum starvation and bacterial survival in macrophages by the bifunctional enzyme SpoT in Helicobacter pylori. J Bacteriol 190: 8025-8032, 2008.
155. Zu Y, Cassai ND, Sidhu GS. Light microscopic and ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori by neutrophils. Ultrastruct Pathol 24: 319-323, 2000.
156. Zullo A, Lorenzetti R, Hassan C. A quintuple therapy for H. pylori eradication. Am J Gastroenterol 102: 2601; author reply 2601-2602, 2007.